Results 271 to 280 of about 80,161 (286)

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.

The Lancet Diabetes and Endocrinology, 2017
K. Birkeland, M. Jørgensen, B. Carstensen, F. Persson, H. Gulseth, M. Thuresson, P. Fenici, D. Nathanson, T. Nyström, J. Eriksson, J. Bodegård, A. Norhammar   +11 more
semanticscholar   +1 more source

Metformin/Sodium-glucose-transporter-2-inhibitors

Reactions Weekly
openaire   +1 more source

Furosemide/sodium-glucose-transporter-2-inhibitors

Reactions Weekly
openaire   +1 more source

Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors

European Journal of Medicinal Chemistry, 2012
Chun-Hsu Yao
exaly  

Sodium‐glucose co‐transporter type‐2 inhibitors: pharmacology and peri‐operative considerations

Anaesthesia, 2018
exaly  

Prednisone/Sodium-glucose transporter 2 inhibitors

Reactions Weekly
openaire   +1 more source

Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trials

Diabetes, obesity and metabolism, 2017
Dandan Li, Tiansheng Wang, S. Shen, Zhen-wei Fang, Yue Dong, Huilin Tang   +5 more
semanticscholar   +1 more source

Sodium Glucose Co-Transporter 2 Inhibitors: Beyond Glucose Lowering

Current Drug Targets, 2018
Asli F Çeylan
exaly  

Acetazolamide/Sodium-glucose transporter 2 inhibitors

Reactions Weekly
openaire   +1 more source

The effect of sodium-glucose transporter 2 inhibitors on stroke in patients with type 2 diabetes: A meta-analysis

Journal of Stroke and Cerebrovascular Diseases
Dg Di Luca, Nicole Sur, Gustavo Oliveira   +2 more
exaly